Open pharmaceutical innovation | Opensource.com

Open pharmaceutical innovation

Posted 02 Jun 2010 by 

Rebecca Fernandez (Red Hat)
Rating: 
(2 votes)
Image by : 

opensource.com

submit to reddit

When it comes to infectious diseases, sharing is generally discouraged. But recently, pharmaceutical giant GlaxoSmithKline (GSK) opened up the designs behind 13,500 chemical compounds, which the company narrowed down from over two million, that may be capable of fighting malaria.

The process of determing which compounds could yield a malaria drug is time consuming and complex, but GSK hopes to inspire other researchers to pool their intellectual property and work together to develop new and better medicines to fight the diseases that are rampant in the world’s poorest countries.

As it turns out, open innovation isn't unique to GSK. Last June, the CEO of Sanofi-Aventis announced his plan to collaborate with smaller companies to improve the ideas coming out of R&D. And shortly thereafter, Pfizer launched its own online community to increase patient and doctor awareness of clinical trials, speeding time-to-market of new drugs.

But there remains greater potential for open innovation within the pharmaceutical industry. In a 2009 issue of Expert Reviews Clinical Pharmacology, Thomas Senderovitz, MD, FCP published a paper entitled "How open innovation could reinvigorate the pharmaceutical industry with fresh R&D opportunities." In it he argues that "healthcare solutions can best be innovated, developed, and probably even marketed through the collaboration of many different companies from different industries sharing their expertise and intellectual property."

The pharmaceutical industry seems to understand this, at least intellectually. We're seeing big names like Johnson & Johnson hail open innovation as the way out of an economic crisis.

But the question remains: Will this industry fully transform its business models to include openness and collaboration as key elements for success?

submit to reddit

1 Comments

Joe Gray

Rebecca:

I just wanted to say thanks for sharing this write-up on open innovation in pharma. I'm doing some research on the subject for a client and was quite pleased to stumble upon this post.

Regards,
Joe

Vote up!
0
Vote down!
0

Rebecca Fernandez works at Red Hat in employment branding. Before that, she was a freelance business writer for 5 years, and before that, a copy writer at Red Hat. (They just couldn't be rid of her.) Rebecca is interested in open source software, education, and the intersection of the open source way with business management models.

Open source project management